

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $110.84
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 16, 26 | Barclays | maintain | Overweight | Overweight |
| Oct 5, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Aug 13, 26 | UBS | downgrade | Buy | Neutral |
| Aug 6, 26 | Barclays | maintain | Overweight | Overweight |
| Aug 5, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Aug 3, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Jul 21, 26 | Barclays | maintain | Overweight | Overweight |
| Jul 8, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Apr 30, 26 | Barclays | maintain | Overweight | Overweight |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 58.89 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 82.51 | Oscillator | Sell |
| Williams %R (14) | -26.33 | Oscillator | Neutral |
| MACD (12, 26, 9) | 2.38 (Hist 0.90) | Oscillator | Strong Buy |
| Average Directional Index (14) | 26.53 (+DI 33.0 / -DI 16.0) | Trend | Strong Buy |
| EMA 20 | 107.70 | MA | Buy |
| SMA 20 | 106.06 | MA | Strong Buy |
| EMA 50 | 105.76 | MA | Strong Buy |
| SMA 50 | 105.57 | MA | Strong Buy |
| SMA 200 | 100.08 | MA | Strong Buy |
Stock news · updated daily
CCEP's 13.9% monthly rally reflects strong category growth, wider distribution and Asian expansion, but premium valuation and rising costs could limit further gains.
CCEP's strong category growth, rising profits and healthy cash flow support its outlook, but a premium valuation and cost pressures call for caution before buying.
CCEP's Southeast Asia revenues rose 9% in the first half of 2026, fueled by gains in the Philippines and Indonesia, as capacity expansion supports future growth.
On October 21, 2026, we conducted a DCF analysis for Coca-Cola Europacific Partners PLC (CCEP), which has shown strong price performance with a year-to-date inc
Vontobel Holding Ltd. lowered its position in shares of Coca-Cola Europacific Partners (NASDAQ: CCEP) by 22.0% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,677 shares of the company's stock after selling 7,791 shares during the quarter. Vontobel Holding Ltd.'s holdings
Coca-Cola Europacific Partners is in the midst of a pullback that may be a buying opportunity. In yield terms, this stock isn't a stunner, but it has the potential to become a solid dividend growth story.
On September 16, 2026, we conducted a DCF analysis for Coca-Cola Europacific Partners PLC (CCEP). The stock has shown a year-to-date increase of 14.7% and a one
Shares of Coca-Cola Europacific Partners (NASDAQ: CCEP - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eleven analysts that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | 2.47 | 2.51 | Beat 1.6% | $12.25B |
| Feb 17, 2026 | 2.40 | 2.45 | Beat 2.1% | $12.48B |
| Aug 6, 2025 | 2.41 | 2.38 | Miss -1.2% | $12.04B |
| Mar 21, 2025 | 2.03 | 2.05 | Beat 1.0% | $11.08B |
| Feb 14, 2025 | 2.03 | 2.05 | Beat 1.0% | $10.57B |
| Aug 7, 2024 | 2.05 | 2.11 | Beat 2.9% | $10.29B |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
FY2025 · 10-K disclosure
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 6-K | Oct 21, 2026 | 2026-10-21 11:35:30 | View |
| 6-K | Oct 19, 2026 | 2026-10-19 10:41:15 | View |
| 6-K | Oct 19, 2026 | 2026-10-19 08:34:17 | View |
| 6-K | Oct 13, 2026 | 2026-10-13 06:10:04 | View |
| 6-K | Oct 5, 2026 | 2026-10-05 08:35:05 | View |
| 6-K | Oct 1, 2026 | 2026-10-01 11:43:49 | View |
| 6-K | Sep 28, 2026 | 2026-09-28 07:52:16 | View |
| 6-K | Sep 21, 2026 | 2026-09-21 09:26:51 | View |
| 6-K | Sep 15, 2026 | 2026-09-15 06:06:48 | View |
| 6-K | Sep 14, 2026 | 2026-09-14 07:38:49 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | CCEP | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 22.3x | 19.6x · sector 38.2x | Discount |
| Forward P/E (FY26E) | 25.2x | EPS est. 4.39 | In line |
| Price / Book | 5.3x | 3.7x | Elevated |
| Price / Sales | 2.1x | 1.6x | Elevated |
| EV / EBITDA | 14.2x | 12.3x | In line |
| Return on equity | 24.8% | — | Top tier |
| Gross margin | 35.6% | 36.2% | In line |
| Debt / Equity | 1.47 | 1.52 | Moderate |
| Piotroski / Altman Z | 7/9 | Z 2.43 | Grey zone |
Discounted cash flow model